Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2024 WS
- Kardiologisch-chirurgische Konferenz (*)
- Tagespraktikum Kardiologie
- Wiss. Arbeiten der Abteilung Kardiologie (*)
- Akute und chronische Herzinsuffizienz
- Kardiovasculäres Kolloquium (*)
- Auskultation und Echokardiografie am Krankenbett (*)
- Klinische Visite Kardiologie (*)
- Blockpraktikum Innere Medizin (PV)
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2020 SS
-
2018 SS
-
2017 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac AmyloidosisIn: Current Heart Failure Reports Jg. 21 (2024) Nr. 3, S. 224 - 237Online Volltext: dx.doi.org/ (Open Access)
-
Current Therapies and Future Horizons in Cardiac Amyloidosis TreatmentIn: Current Heart Failure Reports Jg. 21 (2024) Nr. 4, S. 305 - 321Online Volltext: dx.doi.org/ (Open Access)
-
Detectable troponin below the 99th percentile predicts survival in patients undergoing coronary angiographyIn: International Journal of Cardiology (IJC) Heart & Vasculature Jg. 52 (2024) 101419Online Volltext: dx.doi.org/ (Open Access)
-
FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice : A Pictorial Imaging VignetteIn: JACC Cardiovascular Imaging Jg. 17 (2024) Nr. 7, S. 811 - 823Online Volltext: dx.doi.org/ (Open Access)
-
Herz und Krebs : KardioonkologieIn: Herz: Cardiovascular Diseases Jg. 49 (2024) Nr. 2, S. 111 - 117Online Volltext: dx.doi.org/
-
High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapyIn: Clinical Research in Cardiology Jg. 113 (2024) Nr. 2, S. 301 - 312Online Volltext: dx.doi.org/ (Open Access)
-
Onkologische KardiologieIn: Medizinische Monatsschrift für Pharmazeuten, MMP Jg. 47 (2024) Nr. 5, S. 170 - 179
-
Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapyIn: Basic Research in Cardiology (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Stroke and myocardial infarction induce neutrophil extracellular trap release disrupting lymphoid organ structure and immunoglobulin secretionIn: Nature Cardiovascular Research Jg. 3 (2024) Nr. 5, S. 525 - 540Online Volltext: dx.doi.org/ (Open Access)
-
Update Kardioonkologie : Immuncheckpoint-Inhibitor-TherapieIn: Herz: Cardiovascular Diseases Jg. 49 (2024) Nr. 1, S. 81 - 90Online Volltext: dx.doi.org/
-
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the HeartIn: International Journal of Molecular Sciences (IJMS) Jg. 24 (2023) Nr. 7, 6052Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
ESC-Leitlinie 2022 onkologische Kardiologie : Kardiovaskuläre Nebenwirkungen durch Krebstherapie verstehen und behandelnIn: Herz: Cardiovascular Diseases Jg. 48 (2023) Nr. 1, S. 15 - 22Online Volltext: dx.doi.org/ (Open Access)
-
Frequency and prognosis of CVD and myocardial injury in patients presenting with suspected COVID-19 : The CoV-COR registryIn: International Journal of Cardiology (IJC) Heart & Vasculature Jg. 45 (2023) 101184Online Volltext: dx.doi.org/ (Open Access)
-
Update Kardioonkologie : Anthrazyklin-ChemotherapieIn: Die Kardiologie Jg. 17 (2023) Nr. 6, S. 449 - 460Online Volltext: dx.doi.org/
-
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignanciesIn: European Heart Journal Jg. 43 (2022) Nr. 20, S. 1928 - 1940Online Volltext: dx.doi.org/ (Open Access)
-
Kardiologische Langzeitfolgen nach Malignom-BehandlungIn: MMW - Fortschritte der Medizin Jg. 164 (2022) Nr. 2, S. 48 - 56Online Volltext: dx.doi.org/
-
Medikamentös bedingte KardiomyopathienIn: Deutsche Medizinische Wochenschrift - DMW Jg. 147 (2022) Nr. 23, S. 1513 - 1522Online Volltext: dx.doi.org/
-
PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial InfarctionIn: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 14, 7533Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapyIn: ESC Heart Failure Jg. 9 (2022) Nr. 5, S. 3533 - 3542Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal Jg. 43 (2022) Nr. 4, S. 316 - 329Online Volltext: dx.doi.org/
-
Assessment of coronary artery disease during hospitalization for cancer treatmentIn: Clinical Research in Cardiology Jg. 110 (2021) Nr. 2, S. 200 - 210Online Volltext: dx.doi.org/ (Open Access)
-
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta-analysisIn: ESC Heart Failure Jg. 7 (2020) Nr. 2, S. 423 - 433Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
ECG Changes in Melanoma Patients Undergoing Cancer Therapy : Data from the ECoR RegistryIn: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 7, 2060Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular systemIn: Herz: Cardiovascular Diseases Jg. 45 (2020) S. 645 - 651Online Volltext: dx.doi.org/
-
Evaluating biomarkers as predictors of cancer therapy cardiotoxicity : All you need is a meta-analysis? ReplyIn: European Journal of Heart Failure Jg. 22 (2020) Nr. 7, S. 1285 - 1286Online Volltext: dx.doi.org/ (Open Access)
-
Onkokardiologie : Neue Herausforderungen, neue MöglichkeitenIn: Herz: Cardiovascular Diseases Jg. 45 (2020) S. 619 - 625Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR RegistryIn: Frontiers in Pharmacology Jg. 11 (2020) S. 740Online Volltext: dx.doi.org/ (Open Access)
-
Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients : a meta-analysisIn: European Journal of Heart Failure Jg. 22 (2020) Nr. 2, S. 350 - 361Online Volltext: dx.doi.org/ (Open Access)
-
Cardio-oncology : need for novel structuresIn: European Journal of Medical Research Jg. 24 (2019) Nr. 1, S. 1Online Volltext: dx.doi.org/ (Open Access)
-
Cardiotoxicity from immune checkpoint inhibitorsIn: International Journal of Cardiology (IJC) Heart & Vasculature Jg. 25 (2019) S. 100420Online Volltext: dx.doi.org/ (Open Access)
-
Cardiovascular Adverse Events Associated with BRAF and MEK Inhibitors : A Systematic Review and Meta-analysisIn: JAMA Network Open Jg. 2 (2019) Nr. 8, S. e198890Online Volltext: dx.doi.org/ (Open Access)
-
Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications Jg. 10 (2019) Nr. 1, S. 2312Online Volltext: dx.doi.org/ (Open Access)
-
Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone ReceptorIn: Thyroid Jg. 29 (2019) Nr. 9, S. 1286 - 1301Online Volltext: dx.doi.org/
-
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications Jg. 10 (2019) Nr. 1, S. 2768Online Volltext: dx.doi.org/ (Open Access)
-
Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicityIn: Journal of Thoracic Disease Jg. 10 (2018) S. S4282 - S4295Online Volltext: dx.doi.org/ (Open Access)
-
Real-time pressure-volume analysis of acute myocardial infarction in miceIn: JoVE (2018) Nr. 137, S. e57621Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndromeIn: Experimental Hematology Jg. 44 (2016) Nr. 7, S. 590 - 595.e1Online Volltext: dx.doi.org/ (Open Access)
-
Gfi136N is a novel prognostic marker for the progression of myelodysplastic syndrome to Acute myeloid leukemiaIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 188 - 188
-
Cardiac dysfunction from cancer and cancer therapy : new pathways for the prevention of late cardiotoxicityIn: Basic Research in Cardiology Jg. 116 (2021) Nr. 1, 62Online Volltext: dx.doi.org/ (Open Access)
-
Detectable troponin below the 99th percentile predicts survival in patients with cardiovascular diseaseIn: European Heart Journal Jg. 42 (2021) Nr. Supplement_1, ehab724.1170Online Volltext: dx.doi.org/ (Open Access)
-
Left ventricular global longitudinal strain reduction in patients with melanoma and extra-cardiac immune-related adverse events during immune checkpoint inhibitor therapy
ESC Congress 2020, 29 August – 1 September 2020, Amsterdam, digital,In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3261Online Volltext: dx.doi.org/ (Open Access) -
Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3260Online Volltext: dx.doi.org/ -
Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3250Online Volltext: dx.doi.org/